Stay updated with breaking news from Truth Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF")
Regulatory News: ADOCIA (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company specialized in the development of innovative formulations of proteins and peptides, announces
SAN CLEMENTE, CA / ACCESSWIRE / May 17, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases
ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results ACCESSWIRE 18 May 2021, 06:19 GMT+10 SAN CLEMENTE, CA / ACCESSWIRE / May 17, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today reported its financial and operational results for the three months ended March 31, 2021. Recent Highlights and Accomplishments Increased revenues by 4.6% compared to non COVID-19 pandemic affected same period in 2019 Continued to implement previously mentioned cost sav...
ADOCIA Announces the Live Broadcast of its Annual General Meeting on May 20th, 2021 ADOCIA (Paris:ADOC) (Euronext Paris: FR0011184241 ADOC the company) a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, confirms that it will hold its Annual General Meeting ("AGM") on May 20, 2021 at 10:00 a.m., at Adocia's offices, 115 avenue Lacassagne, 69003, Lyon, France. The Shareholders' Meeting will also be broadcast live on the Company's website (www.adocia.com under "Investors Shareholder Meeting") by audio webcast via conferenc...